Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue
Ricardo J. Samms, Guo‐Fang Zhang, Wentao He, et al.
Molecular Metabolism (2022) Vol. 64, pp. 101550-101550
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Rola Hammoud, Daniel J. Drucker
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 201-216
Closed Access | Times Cited: 127
The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets
Kimberley El, Jonathan D. Douros, Francis S. Willard, et al.
Nature Metabolism (2023) Vol. 5, Iss. 6, pp. 945-954
Open Access | Times Cited: 64
The intestine as an endocrine organ and the role of gut hormones in metabolic regulation
Rula Bany Bakar, Frank Reimann, Fiona M. Gribble
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 784-796
Closed Access | Times Cited: 58
BCAA-nitrogen flux in brown fat controls metabolic health independent of thermogenesis
Anthony R.P. Verkerke, Dandan Wang, Naofumi Yoshida, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2359-2374.e18
Open Access | Times Cited: 29
Transforming obesity: The advancement of multi-receptor drugs
Christine M. Kusminski, Diego Pérez–Tilve, Timo D. Müller, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3829-3853
Closed Access | Times Cited: 24
The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide
Lærke S. Gasbjerg, Mette M. Rosenkilde, Juris J. Meier, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 11, pp. 3079-3092
Closed Access | Times Cited: 24
The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist
Yun Kyung Cho, Yoo La Lee, Chang Hee Jung
Journal of Lipid and Atherosclerosis (2023) Vol. 12, Iss. 3, pp. 213-213
Open Access | Times Cited: 24
Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
Isabella Zaffina, Maria Chiara Pelle, Giuseppe Armentaro, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice
Xinxin Yu, Shiuhwei Chen, Jan‐Bernd Funcke, et al.
Cell Metabolism (2024)
Closed Access | Times Cited: 7
The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue
Samrin Kagdi, Sulayman A. Lyons, Jacqueline L. Beaudry
Journal of Endocrinology (2024) Vol. 261, Iss. 3
Open Access | Times Cited: 6
Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence
Salvatore Corrao, C Pollicino, Dalila Maggio, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Syndromic and Monogenic Obesity: New Opportunities Due to Genetic-Based Pharmacological Treatment
Kallirhoe Kalinderi, Vasiliki Goula, Evdoxia Sapountzi, et al.
Children (2024) Vol. 11, Iss. 2, pp. 153-153
Open Access | Times Cited: 5
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
Stefano Ciardullo, Mario Luca Morieri, GIUSEPPE DANIELE, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 8, pp. 941-950
Open Access | Times Cited: 5
Obesity pharmacotherapy: incretin action in the central nervous system
Geke Aline Boer, Debbie L. Hay, Alexander Tups
Trends in Pharmacological Sciences (2022) Vol. 44, Iss. 1, pp. 50-63
Closed Access | Times Cited: 21
New Mediators in the Crosstalk between Different Adipose Tissues
Almudena Gómez‐Hernández, Natalia de las Heras, Beatriz G. Gálvez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4659-4659
Open Access | Times Cited: 4
Liraglutide improves adipose tissue remodeling and mitochondrial dynamics in a visceral obesity model induced by a high-fat diet
Vanessa Touceda, Florencia Fontana Estevez, Leonardo Cacciagiú, et al.
Current Research in Pharmacology and Drug Discovery (2024) Vol. 6, pp. 100185-100185
Open Access | Times Cited: 4
Tirzepatide mitigates cognitive decline in zebrafish model of type 2 diabetes mellitus induced by high-fat diet
Sakshi Misra, Prabha Rajput, Amandeep Kaur
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice
Mengya Chen, Nan Zhao, Wenke Shi, et al.
Cardiovascular Research (2025)
Closed Access
RNA Modification in Metabolism
Yadi Liu, Zhongyan Sun, Dingkun Gui, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Browning of inguinal white adipose tissue by the novel lignan (−)-secoisolariciresinol 4-O-methyl ether attenuates diet-induced obesity through mitochondrial and Peroxisomal activation
Wenjun Jiao, Woo Yong Park, Young‐Il Kim, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025), pp. 119952-119952
Closed Access
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data
Ioanna A. Anastasiou, Georgia Argyrakopoulou, Μaria Dalamaga, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access
Obesity‐related glomerulopathy: How it happens and future perspectives
Jian‐Wen Samuel Lee‐Boey, Juan Tan, Zi Yi Lim, et al.
Diabetic Medicine (2025)
Open Access
Obesity wars: hypothalamic sEVs a new hope
Sayani Mukherjee, Carlos Diéguez, Johan Fernø, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 8, pp. 622-634
Open Access | Times Cited: 9
Glutamate and obesity – what is the link?
Lila Chaouche, F Marcotte, Ina Maltais‐Payette, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2023) Vol. 27, Iss. 1, pp. 70-76
Closed Access | Times Cited: 9
Heat stress reduces brown adipose tissue activity by exacerbating mitochondrial damage in type 2 diabetic mice
Penghua Lai, Linlin Zhang, Qiu Yan, et al.
Journal of Thermal Biology (2024) Vol. 119, pp. 103799-103799
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top